Our scientists are recognized for their discoveries surrounding stem cell biology and blood formation. One of our research breakthroughs is the discovery that fat cells in bone marrow suppress the recovery of blood cell production following a stem cell transplant (also called bone marrow transplant) in mice. We are now investigating the use of autologous transplants (self-donation of stem cells) for children with neuroblastoma (a cancerous tumor that begins in nerve tissue) and brain tumors, unrelated donor transplants for patients with sickle cell disease, and the long-term consequences of transplants, including pulmonary function and bone health.
Our Stem Cell Transplant Center offers unique access to a range of clinical trials in which children with rare or hard-to-treat conditions have access to innovative treatments that may help where traditional options fail. Our physicians work collaboratively with national research groups, including the Children’s Oncology Group, the Blood and Marrow Clinical Trials Network and the Pediatric Blood and Marrow Transplant Program, to develop innovative clinical trials and expand transplantation for new conditions.
Learn about our current studies below. To inquire about clinical trials, email us at email@example.com and read our clinical trial FAQ for answers to general questions.